Point‐Of‐Care Drug‐Checking: Assessing the Rhode Island Drug Supply Using <scp>FTIR</scp> Spectroscopy to Detect Fentanyl, Xylazine and Other Substances
These findings provide a snapshot of the unpredictable and highly mixed nature of the Rhode Island drug supply defined by stimulant-opioid overlaps, xylazine adulteration and the presence of cocaine across drug categories. By pairing real-time FTIR with laboratory-based analysis, we provided actionable information back to service users while also uncovering deeper patterns in local drug trends.
Authors
- Cole Jarczyk (ORCID: https://orcid.org/0000-0002-0464-8897)
- Erin Thompson (ORCID: https://orcid.org/0000-0001-6451-2679)
- Traci C. Green (ORCID: https://orcid.org/0000-0001-9105-6904)
- Alexis Morales (ORCID: https://orcid.org/0000-0002-5437-9656)
- Ju Nyeong Park (ORCID: https://orcid.org/0000-0001-6490-9887)
- Rachel Serafinski
- Jessica Tardif (ORCID: https://orcid.org/0000-0003-1147-479X)
- Adina Badea (ORCID: https://orcid.org/0000-0002-7077-2810)
- Merci Ujeneza
- Michelle McKenzie (ORCID: https://orcid.org/0000-0001-5047-4413)
Institutions
- Brown University (US)
- Rhode Island Hospital (US)
- Memorial Hospital of Rhode Island (US)
- Rhode Island Spine Center (US)
- Brandeis University (US)
Publication Details
- Journal
- Drug and Alcohol Review
- Published
- 2025-09-21
- DOI
- https://doi.org/10.1111/dar.70037
- Citations
- 2
- Primary Topic
- Forensic Toxicology and Drug Analysis
- Type
- article
- Field-Weighted Citation Impact
- 2.61